Supernus Pharmaceuticals
SUPN
#5354
Rank
NZ$2.85 B
Marketcap
NZ$49.04
Share price
5.58%
Change (1 day)
-39.21%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total assets

Total assets on the balance sheet as of June 2026 : NZ$2.53 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are NZ$2.53 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$2.02 B-24.66%
2022-12-31NZ$2.68 B8.43%
2021-12-31NZ$2.47 B18.63%
2020-12-31NZ$2.08 B21%
2019-12-31NZ$1.72 B18.18%
2018-12-31NZ$1.45 B143.91%
2017-12-31NZ$0.59 B33.73%
2016-12-31NZ$0.44 B62.16%
2015-12-31NZ$0.27 B57.87%
2014-12-31NZ$0.17 B29.25%
2013-12-31NZ$0.13 B18.22%
2012-12-31NZ$0.11 B65.96%
2011-12-31NZ$68.84 M12.98%
2010-12-31NZ$60.93 M-44.61%
2009-12-31NZ$0.11 B-17.24%
2008-12-31NZ$0.13 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$350.56 B 13,724.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$196.08 B 7,632.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$262.93 B 10,268.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$157.63 B 6,116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
NZ$12.82 B 405.57%๐Ÿ‡บ๐Ÿ‡ธ USA